Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group
about
A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications.Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Capecitabine in the treatment of advanced gastric cancer.Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.Survey of Policies and Guidelines on Antioxidant Use for Cancer Prevention, Treatment, and Survivorship in North American Cancer Centers: What Do Institutions Perceive as Evidence?Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney.B Vitamin Complex and Chemotherapy-Induced Peripheral Neuropathy.
P2860
Q34344248-2F435473-E6C5-4E34-BE4C-5AB41781A415Q34451382-00355B89-668D-460A-9CBE-F19B71F0A92AQ34782021-A5E0DF53-DFD4-4765-A36F-F9BE5050FE30Q34973732-7D592B8D-09B9-4457-9720-7147740EEB2CQ36226275-3D55F04D-F96D-4F5D-89C0-A489C289DD3DQ37136996-907FA07E-7DCE-42A8-BA98-13FAFA93605EQ39639803-C35DE488-9F5A-42FA-ABED-5927BCA9FB78Q43429878-AFFB5181-D05C-4686-8E3D-618D25D0E496Q44931712-C35A01BF-53F5-4E4F-B9F2-DBDEC6862A81Q49566831-7CC96D3B-2D22-419A-822C-E25F22F2244A
P2860
Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group
description
1992 nî lūn-bûn
@nan
1992 թուականին հրատարակուած գիտական յօդուած
@hyw
1992 թվականին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@ast
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@en
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@nl
type
label
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@ast
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@en
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@nl
prefLabel
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@ast
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@en
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@nl
P2093
P2860
P1433
P1476
Hexamethylmelamine and low or ...... ern Cooperative Oncology Group
@en
P2093
B Cheuvart
B H Kaplan
P H Wiernik
P2860
P356
10.3109/07357909209032783
P407
P577
1992-01-01T00:00:00Z